US 8598164
Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
granted A61PA61P1/00A61P1/18
Quick answer
US patent 8598164 (Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 68
- CPC classes
- A61P, A61P1/00, A61P1/18, A61P13/00, A61P13/08